AtlasGrace
Member
Long COVID has pushed hundreds of thousands of patients outside conventional treatment frameworks, seeking options for persistent fatigue, brain fog, and other debilitating symptoms that standard medicine has not adequately addressed. HBOT has emerged as one of the more promising alternatives, but for most long COVID patients, it comes with a significant financial burden. Understanding the hyperbaric oxygen therapy cost reality for this population helps patients make financially sustainable treatment decisions.
Why Long COVID HBOT Is Not Covered
Long COVID is not currently among the FDA-cleared indications for hyperbaric oxygen therapy. While clinical research is ongoing and early results are promising, the evidence base has not yet met the regulatory threshold for cleared indication status. Without clearance, Medicare and private insurers do not cover HBOT for long COVID, regardless of how compelling the patient's case may be.This places the full cost burden on patients, most of whom are already dealing with reduced work capacity and income due to their symptoms. The financial reality is challenging but manageable with careful planning.
What Long COVID HBOT Typically Costs
The per-session cost at standalone HBOT clinics ranges from $150 to $400. Most published research protocols for long COVID have used 40 to 60 sessions administered at hard-shell clinical facilities. At $250 per session average, a 40-session course costs $10,000 and a 60-session course costs $15,000.These are significant out-of-pocket expenses. However, some facilities offer specific pricing for long COVID treatment packages that reduce the per-session cost for patients committing to the full course.
Financial Strategies for Long COVID Patients
Several approaches can reduce the effective hyperbaric oxygen therapy cost for long COVID patients:Health savings accounts allow pre-tax payment for HBOT prescribed by a physician, providing a tax discount equivalent to your marginal tax rate. For a $10,000 treatment course, this can save $2,000 to $3,500 depending on your tax bracket.
Flexible spending accounts work similarly for employees whose employers offer FSA plans, though the use-it-or-lose-it nature of FSAs requires careful planning.
Comparing multiple facilities in your area can reveal meaningful pricing differences. Even within the same metro area, per-session prices often vary by $50 to $100, which on a 40-session course represents $2,000 to $4,000 in potential savings.
Insurance appeals while unlikely to succeed given the current off-label status are sometimes worth attempting if you have a compelling medical record and an engaged physician willing to document the case. Some private insurers have covered off-label HBOT for individual patients based on documented medical necessity, though this is uncommon.
Clinical trial participation represents a meaningful cost-reduction option for some patients. Several research institutions are actively enrolling long COVID patients in HBOT trials that provide the therapy at no cost to participants in exchange for contributing to the evidence base.
Setting Realistic Expectations
Before committing $10,000 to $15,000 to an HBOT course for long COVID, patients should understand the current state of evidence. Early clinical trials show meaningful improvements in cognitive function, fatigue, and quality of life. But these are early studies with limited sample sizes, and not all patients respond equally.Patients who have not first optimized other aspects of their long COVID management, including sleep, nutrition, pacing, and any eligible pharmacological treatments, may find that addressing these variables alongside HBOT produces the best overall results. Spending a large amount on HBOT as the first intervention while leaving other modifiable factors unaddressed may produce disappointing results.
Finding the Right Facility for Long COVID
For long COVID, the facility you choose must use clinical-grade hard-shell chambers at 2.0 ATA or higher with 100 percent oxygen. The research protocols showing benefit for long COVID were conducted in these conditions. Soft-chamber facilities offering HBOT for long COVID are not delivering the same therapy documented in research.Additionally, facilities that have experience with long COVID patients and can discuss the current evidence base knowledgeably are preferable to those adding long COVID to a general HBOT menu without specialized protocol knowledge.